Their own payment-practices filing · gov.uk
Shire Pharmaceuticals Group paid suppliers in 53 days on average — inside its 60-day stated terms
Their H2 2020 filing put the average 7 days inside their stated 60-day term.
- Their stated terms
- 60 days
- Paid outside agreed terms
- 26% of invoices
- Paid after 61+ days
- 19%
- Reporting period
- 1 Apr 2020 – 30 Sept 2020
- Source
- their gov.uk filing, filed 28 Oct 2020
Self-reported figures from their statutory filing. How this is compiled.
Terms vs reality · their H2 2020 filing
Paid 7 days inside the 60-day term they state
Where their invoices landed · share of all invoices
The pattern · last 6 of 6 reports
43 → 53 days — slower across the window
The read · computed from their figures
Shire Pharmaceuticals Group's H2 2020 filing put their average at 53 days against stated terms of 60 days; 26% of invoices were paid outside agreed terms and 19% took 61 days or longer. Filed 28 Oct 2020.
The direction is slower: from 43 days in H1 2018 to 53 now — 10 days slower across their last 6 reports.
That is 6 statutory periods on record (earliest H1 2018) — a historical record, not a promise for a new invoice.
What they tell their suppliers
In their own words · from the filing
Standard payment terms
Terms are applied from invoice receipt date
Dispute resolution
Takeda Business Solutions (TBS), is responsible for maintaining supplier information, PO processing, invoice processing and payments. Please note the following important points about contacting us.We operate a ticketing system to ensure all queries are recorded and responded to within agreed timelines.All new queries will be assigned a Case Number and [ref: XXX]These numbers should be quoted on all replies to TBS. You’ll find it in the subject line of our auto-reply. Please use this case number if following up on your email or reply directly to our case email. Query handing email address : [email protected]
Every statutory report on record
Most recent first.
| Period | Avg days | Outside terms | 61+ days | Filed |
|---|---|---|---|---|
| H2 2020 | 53 | 26% | 19% | 28 Oct 2020 |
| H1 2020 | 55 | 32% | 22% | 24 Apr 2020 |
| H2 2019 | 52 | 26% | 19% | 25 Feb 2020 |
| H1 2019 | 44 | 34% | 16% | 30 Jul 2019 |
| H2 2018 | 38 | 53% | 16% | 28 Jan 2019 |
| H1 2018 | 43 | 51% | 16% | 27 Jul 2018 |
Quick answers · Shire Pharmaceuticals Group
Are they getting slower or faster?
What's their typical pay point?
Can I see what this means for my invoices?
Stay ahead
Watch Shire Pharmaceuticals Group (free)
They haven’t filed a payment report since 28 Oct 2020. We watch their public record and email you when something changes — a new payment report, late filings, insolvency markers, new charges.
You’ll get a confirmation email first. Unsubscribe any time. How we handle your address.
How UK payment reporting works
What is a Payment Practices Report?
What does "paid outside agreed terms" mean?
How often is this data updated?
Is this official government data?
How this is compiled. Built from official records only: Companies House and the gov.uk payment-practices service. The payment figures are self-reported — companies over the size threshold must file them by law and the board signs them off. No credit-agency data. The numbers are theirs; the plain-English read is ours. This is information compiled from public records under the Open Government Licence v3.0 — not a credit rating and not advice.
The 31-day comparison figure is the median across 6,104 companies with a current statutory report — every sector pooled, not an average of sector medians (how the figure is built).
Report PL-02883758 · latest period to 30 Sept 2020
Built by YORXEN LTD · registered in England & Wales · CRN 17303256 · privacy · terms.